Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 24
Page 7
... gene expression profiling using DNA microarrays: bronchioid, squamoid, and magnoid (Hayes, et al., 2006). These subtypes correlate with survival and metastatic patterns. Bronchioid tumors are correlated with increased survival in early ...
... gene expression profiling using DNA microarrays: bronchioid, squamoid, and magnoid (Hayes, et al., 2006). These subtypes correlate with survival and metastatic patterns. Bronchioid tumors are correlated with increased survival in early ...
Page 14
... Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. Journal of Clinical Oncology, 24(31), 5079–5090. Hirsch, R., Matthews, M., Aisner, S., Campobasso, O., Elema, J ...
... Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. Journal of Clinical Oncology, 24(31), 5079–5090. Hirsch, R., Matthews, M., Aisner, S., Campobasso, O., Elema, J ...
Page 17
... gene and genome ap- proaches for early detection of lung cancer, as well as potential new therapies. Over the past years, it has become clinically evident that there are nu- merous clonal genetic and epigenetic alternations that lead to ...
... gene and genome ap- proaches for early detection of lung cancer, as well as potential new therapies. Over the past years, it has become clinically evident that there are nu- merous clonal genetic and epigenetic alternations that lead to ...
Page 18
... gene ex- pression. Additionally, gene microarrays allow the review of thousands of genes compromising lung cancer. The ability to examine DNA alternations has led to the outlining of genetic damage and development of genetic and ...
... gene ex- pression. Additionally, gene microarrays allow the review of thousands of genes compromising lung cancer. The ability to examine DNA alternations has led to the outlining of genetic damage and development of genetic and ...
Page 19
... gene amplification. Point mutations are specific areas of alteration in the DNA molecule, such as re- placement of cytosine for tyrosine. Chromosomal translocations occur when part of a gene is physically moved to another part of the gene ...
... gene amplification. Point mutations are specific areas of alteration in the DNA molecule, such as re- placement of cytosine for tyrosine. Chromosomal translocations occur when part of a gene is physically moved to another part of the gene ...
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss